BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
93 results:

  • 1. A novel β-cyclodextrin-assisted enhancement strategy for portable and sensitive detection of miR-21 in human serum.
    Yao F; Wu L; Xiong Y; Su C; Guo Y; Bulale S; Zhou M; Tian Y; He L
    Anal Methods; 2024 Mar; 16(11):1639-1648. PubMed ID: 38414387
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
    Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
    Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software.
    Seregin AA; Smirnova LP; Dmitrieva EM; Zavialova MG; Simutkin GG; Ivanova SA
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894929
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
    Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
    Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Myeloid/lymphoid neoplasm with eosinophilia and BCR/fgfr1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults.
    Lv K; Chen H; Cao X; Du P; Chen J; Liu X; Zhu L; Geng D; Zhang J
    J Neurosurg; 2023 Aug; 139(2):393-401. PubMed ID: 36681946
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
    Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
    Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
    Kim AS; Pozdnyakova O
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):643-651. PubMed ID: 35478091
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-fgfr1 rearrangement: A case report and literature review.
    Washburn E; Bayerl MG; Ketterling RP; Malysz J
    Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype].
    Xue S; Xu HX; Zhang YP; Liu FH; Lu YY; Li F; Wang YP; Wang CC; Jia XP; Wang JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):181-187. PubMed ID: 33554816
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin lymphoma.
    Gamboa-Cedeño AM; Díaz M; Cristaldo N; Otero V; Schutz N; Fantl D; Cugliari S; Zerga M; Rojas-Bilbao E; Jauk F; García Rivello H; Nuñez M; Ranuncolo SM
    Life Sci; 2021 Mar; 268():118979. PubMed ID: 33421528
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or fgfr1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
    Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
    Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
    Bornhauser B; Cario G; Rinaldi A; Risch T; Rodriguez Martinez V; Schütte M; Warnatz HJ; Scheidegger N; Mirkowska P; Temperli M; Möller C; Schumich A; Dworzak M; Attarbaschi A; Brüggemann M; Ritgen M; Mejstrikova E; Hofmann A; Buldini B; Scarparo P; Basso G; Maglia O; Gaipa G; Skoblyn TL; Te Kronnie G; Vendramini E; Panzer-Grümayer R; Barz MJ; Marovca B; Hauri-Hohl M; Niggli F; Eckert C; Schrappe M; Stanulla M; Zimmermann M; Wollscheid B; Yaspo ML; Bourquin JP
    Blood Adv; 2020 Sep; 4(17):4052-4064. PubMed ID: 32853382
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
    Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
    Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
    Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Expression of sB7-H4 in Serum and lymphoma Tissues of Patients with Malignant lymphoma and Its Value for diagnosis and Re-Examine of lymphoma].
    Liang XP; Yang HL; Shao MM; Li N; Li XF; Liu B; Li HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1355-1359. PubMed ID: 30295250
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [fgfr1-mutated B-cell acute lymphoblastic leukemia transforming to myelodysplastic / myeloproliferative neoplasm and acute myeloid leukemia].
    Ide S; Ohara S; Inoue M; Hua J; Hagihara M
    Rinsho Ketsueki; 2018; 59(7):872-877. PubMed ID: 30078796
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.